Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2

The Journal of Antibiotics
2013.0

Abstract

Because stromal cells can regulate the growth and metastasis of tumor cells, a compound that modulates the interaction between the stromal cells and the tumor cells can control the tumor progression. In the course of our screening for such a compound, we have isolated a new compound, intervenolin, from the culture broth of Nocardia sp. ML96-86F2. Intervenolin inhibits the growth of human gastric and colorectal cancer cell lines in the coculture with the respective organ-derived stromal cells more strongly than that of the cancer cells cultured alone. Intervenolin shows antitumor effect against a xenograft model of human colorectal cancer cells in vivo. Furthermore, intervenolin exerts selective anti-Helicobacter pylori effect.

Knowledge Graph

Similar Paper

Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2
The Journal of Antibiotics 2013.0
NBRI16716A, a new antitumor compound against human prostate cancer cells, produced by Perisporiopsis melioloides Mer-f16716
The Journal of Antibiotics 2010.0
NA22598Al, a Novel Antitumor Substance Produced by Streptomyces sp. NA22598.
The Journal of Antibiotics 1997.0
Identification of 3′,4′,5′-trimethoxychalcone analogues as potent inhibitors of Helicobacter pylori-induced inflammation in human gastric epithelial cells
Bioorganic & Medicinal Chemistry Letters 2010.0
New Quinolone Compounds from Pseudonocardia sp. with Selective and Potent Anti-Helicobacter pylori Activity: Taxonomy of Producing Strain, Fermentation, Isolation, Structural Elucidation and Biological Activities.
The Journal of Antibiotics 1998.0
The antiproliferative effect of spectinabilins from Streptomyces spectabilis on hepatocellular carcinoma cells in vitro and in vivo
Bioorganic Chemistry 2019.0
A specific anti-Helicobacter pylori agent NE2001: synthesis and its effect on the growth of H. pylori
Bioorganic & Medicinal Chemistry Letters 2003.0
Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G
Bioorganic & Medicinal Chemistry Letters 2006.0
BE-32030 A, B, C, D and E, New Antitumor Substances Produced by Nocardia sp. A32030.
The Journal of Antibiotics 1997.0
Synthesis and biological evaluation of cinnamyl compounds as potent antitumor agents
Bioorganic & Medicinal Chemistry Letters 2007.0